Senators Tuesday unanimously passed the right-to-try legislation that would give patients access to treatments that have cleared the first phase of the Food and Drug Administration’s approval process.
The inspector general’s office at the Department of Veterans Affairs is defending its actions after the office came under unusual criticism from its counterpart at the Treasury Department.
The new Dementia Discovery Fund will function like a venture capital fund. It will identify promising laboratory discoveries in Alzheimer’s disease and other forms of dementia.
Federal agencies set a new record for improper payments last year, shelling out $125 billion in questionable benefits after years of declines.
Attorney General Greg Zoeller announced that the settlement with Indiana, 48 other states and the federal government will resolve five lawsuits against a pharmaceutical company.
Those requesting euthanasia are mainly highly educated and between 65 and 79, the study found. Cancer patients form the biggest group.
Democratic senators would oppose a potential House bipartisan deal preventing cuts in physicians’ Medicare payments if it doesn’t finance a children’s health program for four years, senior Senate Democratic aides said Sunday.
The days are long, spent seeing dozens of patients, but are an important part of giving back.
The results are “really impressive and very encouraging” for the new drugs, said one independent expert.
The world’s biggest beverage maker is working with fitness and nutrition experts who suggest its cola as a healthy treat.
The CDC did not specify how many Americans are coming back, but medical officials said they will be monitoring four Americans.
The FDA warned consumers about the potential contamination in Blue Bell Creameries’ products.